Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB
Skip to main content Skip to main navigation menu Skip to site footer
Bleeding, Thrombosis and Vascular Biology

Editor-in-Chief: Giovanni de Gaetano, Italy | eISSN: 2785-5309

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Copyright
  • Supplements
    • ICTHIC 2026
    • SISET 2025
    • ICTHIC 2024
  • Register
  • Login
  • Search
  • Contacts
0.5
Impact Factor 2025
0.6
CiteScore 2025
This journal has not published any issues.
0.5
Impact Factor 2025
0.6
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Efficacy, safety and surgical management with concizumab prophylaxis in three young patients affected by severe hemophilia with inhibitors

    Silvia Linari, Lisa Pieri, Raffaella Pasquino, Eleonora Piellucci, Monica Attanasio, Francesca Salvianti, Giancarlo Castaman
    11-05-2026
    https://doi.org/10.4081/btvb.2026.467
    1263
    PDF: 186
  • Pharmacokinetics of extended half-life albumin-fused factor IX and heterogeneous F9 variants in hemophilia B: a retrospective cohort study

    Barbara Lunghi, Massimo Morfini, Silvia Linari, Dario Balestra, Alessio Branchini, Lisa Pieri, Donata Belvini, Laura Banov, Cristina Santoro, Giancarlo Castaman, Francesco Bernardi
    02-03-2026
    https://doi.org/10.4081/btvb.2026.413
    379
    PDF: 120
    Supplementary: 87
  • Gene transfer in hemophilia B: a big step forward

    Giancarlo Castaman
    17-05-2023
    https://doi.org/10.4081/btvb.2023.70
    1393
    PDF: 624
  • Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers

    Ezio Zanon, Giancarlo Castaman, Augusto Bramante Federici, Maria Elisa Mancuso, Gianfranco Pasut, Alberto Tosetto, Angiola Rocino, Rita Carlotta Santoro
    26-01-2026
    https://doi.org/10.4081/btvb.2026.415
    1185
    PDF: 317
    HTML: 144
  • Hemophilia-free mind: a call to action

    Tiziano Martini, Chiara Gorio, Cristina Dainese, Rita Carlotta Santoro, Giancarlo Castaman
    10-03-2026
    https://doi.org/10.4081/btvb.2026.465
    494
    PDF: 117
  • Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

    Marco Marietta, Giancarlo Castaman
    01-07-2025
    https://doi.org/10.4081/btvb.2025.180
    1877
    PDF: 532
  • Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes

    Lisa Pieri, Silvia Linari, Francesca Salvianti, Monica Attanasio, Giancarlo Castaman
    27-11-2024
    https://doi.org/10.4081/btvb.2024.150
    1355
    PDF: 421
  • Development of a shared decision-making tool for gene therapy in hemophilia A in Italy

    Giovanni Di Minno, Sarah Bigi, Serena Barello, Enrico Ferri Grazzi, Marco Follino, Maria Francesca Mansueto, Mariasanta Napolitano, Rita Carlotta Santoro, Giancarlo Castaman
    22-06-2026
    https://doi.org/10.4081/btvb.2026.426
    856
    PDF: 104
    SUPPLEMENTARY MATERIAL: 61
  • The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

    Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno
    04-09-2024
    https://doi.org/10.4081/btvb.2024.144
    1989
    PDF: 348
    SUPPLEMENTARY MATERIAL: 204
1 - 9 of 9 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article
  • Index of Authors

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
Vol. 5 No. 3 (2026): In memory of Armando...
Trypsin is as procoagulant as factor XIIa
Stephanie A. Smith et al.
28 August 2026
Vol. 5 No. 3 (2026): In memory of Armando...
A case of inadvertent overdose with argatroban in a 13-month-old toddler in the cardiac catheterization lab setting
Charles E. Mahan
28 August 2026
Vol. 5 No. 3 (2026): In memory of Armando...
Perioperative management of patients taking direct oral anticoagulants: challenges in high-bleed-risk surgery and neuraxial anesthesia
Maria P. Ntalouka et al.
28 August 2026
Vol. 5 No. 3 (2026): In memory of Armando...
Inflammation and hemostatic system: a selection of involved clinical disorders
Francesco Marongiu et al.
28 August 2026

indexing

INDEXING
  • Scopus
  • Web of Science
  • DOAJ
  • Google Scholar
  • OpenAlex
  • Analytics

Keywords

Bleeding, Thrombosis and Vascular Biology

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

eISSN: 2785-5309

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors
Themes by Openjournaltheme.com

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.